1. Antibiotics in the pipeline: a literature review (2017–2020)

   • Jaffar A. Al-Tawfiq
   • Hisham Momattin
   • Patricia Schlagenhauf

   Review 04 October 2021 Pages: 553 - 564

   

2. Correction to: Antibiotics in the pipeline: a literature review (2017–2020)

   • Jaffar A. Al-Tawfiq
   • Hisham Momattin
   • Patricia Schlagenhauf

   Correction 10 March 2022 Pages: 565 - 567

3. In search for a synergistic combination against pandrug-resistant A. baumannii; methodological considerations

   • Stamatis Karakonstantis
   • Petros Ioannou
   • Diamantis D. Kofteridis

   Review 04 January 2022 Pages: 569 - 581

   

4. Implication of the emergence of the delta (B.1.617.2) variants on vaccine effectiveness

   • Jaffar A. Al-Tawfiq
   • Thoyaja Koritala
   • Philippe Gautret

   Review 03 February 2022 Pages: 583 - 596

   

5. Diagnostic accuracy of the interferon-gamma release assay in acquired immunodeficiency syndrome patients with suspected tuberculosis infection: a meta-analysis

   • Hao Chen
   • Atsushi Nakagawa
   • Nobuhiko Seki

   Review Open access 06 March 2022 Pages: 597 - 606

   

6. Mobile PCR-based surveillance for SARS-CoV-2 to reduce visiting restrictions in nursing homes during the COVID-19 pandemic: a pilot study

   • Jannik Stemler
   • Theresa Kramer
   • Oliver A. Cornely

   Original Paper Open access 20 October 2021 Pages: 607 - 616

   

7. Humoral response to SARS-CoV-2 vaccines in people living with HIV

   • Sebastian Noe
   • Nino Ochana
   • Celia Jonsson-Oldenbuettel

   Original Paper 25 October 2021 Pages: 617 - 623

   

8. Analytical performance of the point-of-care BIOSYNEX COVID-19 Ag BSS for the detection of SARS‐CoV‐2 nucleocapsid protein in nasopharyngeal swabs: a prospective field evaluation during the COVID-19 third wave in France

   • Frédéric Fitoussi
   • Serge Tonen-Wolyec
   • Laurent Bélec

   Original Paper Open access 24 October 2021 Pages: 625 - 633

9. Dynamics of urinary and respiratory shedding of Severe acute respiratory syndrome virus 2 (SARS-CoV-2) RNA excludes urine as a relevant source of viral transmission

   • Jan-Niclas Mumm
   • Stephan Ledderose
   • Severin Rodler

   Original Paper Open access 30 October 2021 Pages: 635 - 642

   

10. High seroprevalence of SARS-CoV-2 among high-density communities in Saudi Arabia

    • Sami Almudarra
    • Shady Kamel
    • Hani Jokhdar

    Original Paper 08 December 2021 Pages: 643 - 649

11. Call, chosen, HA₂T₂, ANDC: validation of four severity scores in COVID-19 patients

    • Selina Wolfisberg
    • Claudia Gregoriano
    • Philipp Schuetz

    Original Paper 19 November 2021 Pages: 651 - 659

    

12. Comparison of fatigue, cognitive dysfunction and psychological disorders in post-COVID patients and patients after sepsis: is there a specific constellation?

    • Andreas Stallmach
    • Miriam Kesselmeier
    • Philipp A. Reuken

    Original Paper Open access 07 January 2022 Pages: 661 - 669

    

13. Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society

    • Carla Colombo
    • Marco Cipolli
    • Gianfranco Alicandro

    Original Paper 07 December 2021 Pages: 671 - 679

    

14. Therapeutic efficacy of chloroquine for uncomplicated Plasmodium vivax malaria in southeastern and western border areas of Myanmar

    • Myat Thu Soe
    • Pyae Linn Aung
    • Liwang Cui

    Original Paper 16 January 2022 Pages: 681 - 688

    

15. Bedside risk prediction for positive follow-up blood culture in Gram-negative bacilli bacteremia: for whom is follow-up blood culture useful?

    • Haein Kim
    • Hyeonji Seo
    • Yong Pil Chong

    Original Paper 21 January 2022 Pages: 689 - 697

    

16. No evidence of harmful effects of steroids in severe exacerbations of COPD associated with influenza

    • Severin Studer
    • Frank Rassouli
    • Werner C. Albrich

    Original Paper 29 January 2022 Pages: 699 - 707

17. Sex differences in COVID-19 mortality in the Netherlands

    • Annabel Niessen
    • Anne C. Teirlinck
    • Mirjam J. Knol

    Original Paper Open access 09 February 2022 Pages: 709 - 717

    

18. Can microalbuminuria be an ındicator of renal ınvolvement in pediatric Covid 19 patients?

    • Sare Gülfem Özlü
    • Zehra Aydın
    • Umut Selda Bayrakçı

    Original Paper 30 January 2022 Pages: 719 - 724

19. Body mass index and risk of clostridioides difficile infection: a systematic review and meta-analysis

    • Nipith Charoenngam
    • Ben Ponvilawan
    • Patompong Ungprasert

    Original Paper 05 January 2022 Pages: 725 - 737

    

20. Lower serum levels of vitamin D in adults with urinary tract infection

    • Lingling Liu
    • Kehang Xie
    • Cheng Wang

    Original Paper 10 January 2022 Pages: 739 - 746

    

21. COVID-19: vaccination vs. hospitalization

    • Oguz Uzun
    • Tekin Akpolat
    • Oya Itil

    Original Paper 04 January 2022 Pages: 747 - 752

22. Predictive value of surveillance cultures for bacteremia caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales among patients with hematological diseases

    • Takuya Hattori
    • Tatsunori Goto
    • Koichi Miyamura

    Original Paper 10 January 2022 Pages: 753 - 759

    

23. Molecular SARS-CoV-2 surveillance in Bavaria shows no Omicron transmission before the end of November 2021

    • Jennifer Flechsler
    • Ute Eberle
    • Bavarian SARS-CoV-Public Health Laboratory Team

    Brief Report Open access 01 March 2022 Pages: 761 - 766

    

24. The impact of COVID-19 pandemic control on vaccine-preventable invasive bacterial diseases in Piedmont (Italy)

    • Marco Peradotto
    • A. Bondi
    • R. Cavallo

    Brief Report 16 February 2022 Pages: 767 - 770

    

25. High titer of antibody against the SARS-CoV-2 spike protein among patients receiving neutralizing antibody cocktail therapy with REGN-COV

    • Hiroaki Sasaki
    • Nobuyuki Miyata
    • Natsuo Tachikawa

    Brief Report 18 February 2022 Pages: 771 - 774

    

26. A case series of severe breakthrough infections observed in nine patients with COVID-19 in a southwestern German university hospital

    • Bettina Lange
    • Sybille Welker
    • Alexandra Heininger

    Case Report 16 March 2022 Pages: 775 - 782

27. Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series

    • Susanne Rüfenacht
    • Pascal Gantenbein
    • Werner C. Albrich

    Case Report 15 April 2022 Pages: 783 - 790

    

28. Prior SARS-CoV-2 infection increases reactogenicity after SARS-COV-2 mRNA vaccine and could delay the administration of the vaccine based on timing of infection

    • Roberto Stellini
    • Renzo Gianello
    • Walter Gomarasca

    Correspondence 02 December 2021 Pages: 791 - 793

29. Sensitivity of SARS-CoV-2 variant Delta to serum neutralization in BNT162b2 vaccinees and unvaccinated COVID-19 recovered cases

    • Enagnon Kazali Alidjinou
    • Julie Demaret
    • the Lille COVID Research Network (LICORNE)

    Correspondence 18 November 2021 Pages: 795 - 797

    

30. Unexpected community-acquired co-infections during an ongoing pandemic: (one) too many diagnoses at once

    • David Manuel Cordas dos Santos
    • Laura Fischer
    • Elham Khatamzas

    Images in Infection Open access 03 July 2021 Pages: 799 - 801